Concepedia

Yu Jin

YJ

Statistics

Publications

11

Citations

472

H-Index

11

Active since

2009

Affiliations

Catholic University of Korea(Current)

Novartis (United States)

The University of Adelaide

Novartis (India)

Hospital Ramos Mejía

Yu Jin is an author at Catholic University of Korea specializing in medicine, pharmacology, and chronic myeloid leukemia therapy.

Publications per year

2009–2018

11

Publications

11

Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase

François-Xavier Mahon, Carla Boquimpani, Dong‐Wook Kim et al. · Annals of Internal Medicine · 2018 · 132 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations

Song Tar Toh, Yu Jin, Lu Liu et al. · Carcinogenesis · 2012 · 108 citations

Life Sciences, Genetics, Molecular Biology +17

Vascular smooth muscle cell-derived adiponectin: A paracrine regulator of contractile phenotype

Min Ding, Ana Catarina Ribeiro Carrao, Róbert Wágner et al. · Journal of Molecular and Cellular Cardiology · 2011 · 62 citations

Life Sciences, Cell Biology, Physiology +13

24 Months Update of the TOPS Study: a Phase III, Randomized, Open-Label Study of 400mg/d (SD-IM) Versus 800mg/d (HD-IM) of Imatinib Mesylate (IM) in Patients (Pts) with Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP).

Michele Baccarani, Brian Druker, Jörge E. Cortes et al. · Blood · 2009 · 34 citations

Medicine, Pharmacology, Pharmacotherapy +4

Ipsilesional High Frequency Repetitive Transcranial Magnetic Stimulation Add-On Therapy Improved Diffusion Parameters of Stroke Patients with Motor Dysfunction: A Preliminary DTI Study

Zhiwei Guo, Yu Jin, Haitao Peng et al. · Neural Plasticity · 2016 · 31 citations · Full text

Medicine, Neurology, Neuroscience +15

1–5 of 11